94 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
to support our strategy in three key areas: Focus on commercial execution after restructuring operations Maximizing free cash flows, moving towards … Factor) and APRIL (A Proliferation-Inducing Ligand) Alarming Proposals from Lucien Selce As part of Aurinia’s strategy, the Company is always open
8-K
EX-99.1
g3ug1kor
15 Feb 24
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
6:06am
8-K
EX-10.1
wmx3wo
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
8-K
EX-99.1
o3cnn72nh a733zh5
21 Aug 23
Dr. Daniel G. Billen appointed Chair of the Board of Directors
4:11pm
DEFA14A
cl2xyquyba9ng
8 May 23
Additional proxy soliciting materials
4:04pm
PX14A6G
jpla 5lh6it2ihdwf
26 Apr 23
Letter to shareholders
10:20am